These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 30188914

  • 1. Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Hegerle N, Choi M, Sinclair J, Amin MN, Ollivault-Shiflett M, Curtis B, Laufer RS, Shridhar S, Brammer J, Toapanta FR, Holder IA, Pasetti MF, Lees A, Tennant SM, Cross AS, Simon R.
    PLoS One; 2018; 13(9):e0203143. PubMed ID: 30188914
    [Abstract] [Full Text] [Related]

  • 2. The O-glycan is essential for the induction of protective antibodies against lethal infection by flagella A-bearing Pseudomonas aeruginosa.
    Choi M, Shridhar S, Fox H, Luo K, Amin MN, Tennant SM, Simon R, Cross AS.
    Infect Immun; 2024 Mar 12; 92(3):e0042723. PubMed ID: 38391207
    [Abstract] [Full Text] [Related]

  • 3. Progress towards the development of Klebsiella vaccines.
    Choi M, Tennant SM, Simon R, Cross AS.
    Expert Rev Vaccines; 2019 Jul 12; 18(7):681-691. PubMed ID: 31250679
    [Abstract] [Full Text] [Related]

  • 4. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S, Safarloo M, Amirmozafari N, Nikokar I, Siadat SD, Holder IA, Mahdavi M.
    APMIS; 2014 Feb 12; 122(2):115-27. PubMed ID: 23758581
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice.
    Campodónico VL, Llosa NJ, Bentancor LV, Maira-Litran T, Pier GB.
    Infect Immun; 2011 Aug 12; 79(8):3455-64. PubMed ID: 21628521
    [Abstract] [Full Text] [Related]

  • 6. Protective efficacy of recombinant exotoxin A--flagellin fusion protein against Pseudomonas aeruginosa infection.
    Farajnia S, Peerayeh SN, Tanomand A, Majidi J, Goudarzi G, Naghili B, Rahbarnia L.
    Can J Microbiol; 2015 Jan 12; 61(1):60-4. PubMed ID: 25496361
    [Abstract] [Full Text] [Related]

  • 7. A Semi-Synthetic Glycoconjugate Vaccine Candidate for Carbapenem-Resistant Klebsiella pneumoniae.
    Seeberger PH, Pereira CL, Khan N, Xiao G, Diago-Navarro E, Reppe K, Opitz B, Fries BC, Witzenrath M.
    Angew Chem Int Ed Engl; 2017 Nov 06; 56(45):13973-13978. PubMed ID: 28815890
    [Abstract] [Full Text] [Related]

  • 8. Toll/IL-1R domain-containing adaptor protein (TIRAP) is a critical mediator of antibacterial defense in the lung against Klebsiella pneumoniae but not Pseudomonas aeruginosa.
    Jeyaseelan S, Young SK, Yamamoto M, Arndt PG, Akira S, Kolls JK, Worthen GS.
    J Immunol; 2006 Jul 01; 177(1):538-47. PubMed ID: 16785551
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
    Bakht Azad S, Nikokar I, Faezi S, Rasooly S, Mahdavi M.
    Microb Pathog; 2018 Oct 01; 123():426-432. PubMed ID: 30075242
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vaccination with a trivalent Klebsiella pneumoniae vaccine confers protection in a murine model of pneumonia.
    Chen Z, Gou Q, Yuan Y, Zhang X, Zhao Z, Liao J, Zeng X, Jing H, Jiang S, Zhang W, Zeng H, Huang W, Zou Q, Zhang J.
    Vaccine; 2024 Oct 03; 42(23):126217. PubMed ID: 39163713
    [Abstract] [Full Text] [Related]

  • 12. A trivalent vaccine consisting of "flagellin A+B and pilin" protects against Pseudomonas aeruginosa infection in a murine burn model.
    Hashemi FB, Behrouz B, Irajian G, Laghaei P, Korpi F, Fatemi MJ.
    Microb Pathog; 2020 Jan 03; 138():103697. PubMed ID: 31465785
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma.
    Campbell WN, Hendrix E, Cryz S, Cross AS.
    Clin Infect Dis; 1996 Jul 03; 23(1):179-81. PubMed ID: 8816151
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Early protection by vaccines in burns.
    Jones RJ.
    Br J Exp Pathol; 1971 Feb 03; 52(1):100-9. PubMed ID: 4993954
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protection against Pseudomonas aeruginosa infection by passive transfer of anti-flagellar serum.
    Drake D, Montie TC.
    Can J Microbiol; 1987 Sep 03; 33(9):755-63. PubMed ID: 3121159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.